欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Resminostat_864814-88-0_产品详情
864814-88-0
  • names:

    Resminostat

  • CAS号:

    864814-88-0

    MDL Number:
  • MF(分子式): C16H19N3O4S MW(分子量): 349.4
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Resminostat
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM002479-10mg 10mg ¥ 2430.00 ¥ 2430.00 Backorder
- +
¥ 0.00
YZM002479-5mg 5mg >97% ¥ 1430.00 ¥ 1430.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 864814-88-0
Inchi
InchiKey
分子式 Formula C16H19N3O4S
分子量 Molecular Weight 349.4
溶解度Solubility
性状
储藏条件 Storage conditions 请根据产品建议的存储条件进行存储,Please store the product under the recommended condition sin the description.
Resminostat(CAS:864814-88-0)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 Resminostat 是一种有效的HDAC1,HHDAC3和HDAC6抑制剂,IC50值分别为 42.5,50.1,71.8 nM,同时对 HDAC8 有较弱的抑制作用,IC50值为 877 nM
IntroductionResminostat is a potent inhibitor of HDAC1,HDAC3andHDAC6, with meanIC50values of 42.5, 50.1, 71.8 nM, respectively, and shows less potent activities against HDAC8, with anIC50of 877 nM.
Application1
Application2
Application3
Resminostat 是一种有效的HDAC1,HHDAC3和HDAC6抑制剂,IC50值分别为 42.5,50.1,71.8 nM,同时对 HDAC8 有较弱的抑制作用,IC50值为 877 nM。Resminostat is a potent inhibitor ofHDAC1,HDAC3andHDAC6, with meanIC50values of 42.5, 50.1, 71.8 nM, respectively, and shows less potent activities against HDAC8, with anIC50of 877 nM.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Mandl-Weber S, et al. The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells. Br J Haematol. 2010 May;149(4):518-28.
【2】.Enzenhofer E, et al. Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines. Head Neck. 2017 May;39(5):900-907.
【3】.Peng X, et al. mTOR inhibition sensitizes human hepatocellular carcinoma cells to resminostat. Biochem Biophys Res Commun. 2016 Sep 2;477(4):556-562.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents